Movement Alert｜Insilico Medicine Declines 5.66% in Regular Trading, Abu Dhabi Dual Listing Hopes Dashed Amid Lock-Up Expiry Concerns

Market Focus05-29

On May 29, Insilico Medicine fell 5.66% in regular trading, trading at 42.88 HKD/share, with trading volume of approximately 58.04 million HKD.

On the news front, the company issued a voluntary announcement on May 27 clarifying that it currently has no definite plans for a second listing in Abu Dhabi. The market had previously anticipated the move would broaden international financing channels and deepen the company's Middle East strategic footprint. The clarification dampened short-term sentiment. Additionally, having listed on the Hong Kong Stock Exchange in December last year, the company is now approaching the lock-up expiry window for certain early investors, raising concerns over potential selling pressure.

Within the Life Sciences Tools & Services sector, performance diverged. WuXi AppTec rose 2.95%, WuXi Biologics gained 0.86%, while XtalPi fell 2.91%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1175029897?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-29 09:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175029897","market":"us","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Declines 5.66% in Regular Trading, Abu Dhabi Dual Listing Hopes Dashed Amid Lock-Up Expiry Concerns","media":"Market Focus","content":"<p><p>On May 29, Insilico Medicine fell 5.66% in regular trading, trading at 42.88 HKD/share, with trading volume of approximately 58.04 million HKD.</p><p>On the news front, the company issued a voluntary announcement on May 27 clarifying that it currently has no definite plans for a second listing in Abu Dhabi. The market had previously anticipated the move would broaden international financing channels and deepen the company's Middle East strategic footprint. The clarification dampened short-term sentiment. Additionally, having listed on the Hong Kong Stock Exchange in December last year, the company is now approaching the lock-up expiry window for certain early investors, raising concerns over potential selling pressure.</p><p>Within the Life Sciences Tools &amp; Services sector, performance diverged. WuXi AppTec rose 2.95%, WuXi Biologics gained 0.86%, while XtalPi fell 2.91%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Declines 5.66% in Regular Trading, Abu Dhabi Dual Listing Hopes Dashed Amid Lock-Up Expiry Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Declines 5.66% in Regular Trading, Abu Dhabi Dual Listing Hopes Dashed Amid Lock-Up Expiry Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-29 09:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 29, Insilico Medicine fell 5.66% in regular trading, trading at 42.88 HKD/share, with trading volume of approximately 58.04 million HKD.</p><p>On the news front, the company issued a voluntary announcement on May 27 clarifying that it currently has no definite plans for a second listing in Abu Dhabi. The market had previously anticipated the move would broaden international financing channels and deepen the company's Middle East strategic footprint. The clarification dampened short-term sentiment. Additionally, having listed on the Hong Kong Stock Exchange in December last year, the company is now approaching the lock-up expiry window for certain early investors, raising concerns over potential selling pressure.</p><p>Within the Life Sciences Tools &amp; Services sector, performance diverged. WuXi AppTec rose 2.95%, WuXi Biologics gained 0.86%, while XtalPi fell 2.91%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1175029897","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175029897","pubTimestamp":1780019807,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 29, Insilico Medicine fell 5.66% in regular trading, trading at 42.88 HKD/share, with trading volume of approximately 58.04 million HKD.On the news front, the company issued a voluntary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动向提示|英矽智能常规交易跌5.66%禁售期担忧阿布扎比双重上市希望破灭","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On May 29, Insilico Medicine fell 5.66% in regular trading, trading at 42.88 HKD/share, with trading volume of approximately 58.04 million HKD.On the news front, the company issued a voluntary announcement on May 27 clarifying that it currently has no definite plans for a second listing in Abu Dhabi. The market had previously anticipated the move would broaden international financing channels and deepen the company's Middle East strategic footprint. The clarification dampened short-term sentiment. Additionally, having listed on the Hong Kong Stock Exchange in December last year, the company is now approaching the lock-up expiry window for certain early investors, raising concerns over potential selling pressure.Within the Life Sciences Tools & Services sector, performance diverged. WuXi AppTec rose 2.95%, WuXi Biologics gained 0.86%, while XtalPi fell 2.91%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1175029897","isCrawlerRequest":true}